ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Molecular Profiling of Glioblastoma Patient-Derived Single Cells Using Combined MALDI-MSI and MALDI-IHC

The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade

Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma

Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndrome

A Bi-Specific T Cell-Engaging Antibody Shows Potent Activity, Specificity, and Tumor Microenvironment Remodeling in Experimental Syngeneic and Genetically Engineered Models of GBM

Molecular and spatial analysis of tertiary lymphoid structures in Sjogren’s syndrome

Altered inflammatory mucosal signatures within their spatial and cellular context during active ileal Crohn’s disease

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence

Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence